4
Changes in Ownership
Vanda Pharmaceuticals Inc. Filed Acc 0001209191-22-060225
SVP, CFO & Treasurer sold 4,792 shares at $10.61 ($50,827)
- SVP, CFO & Treasurer acquired 7,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Moran Kevin Patrick · SVP, CFO & Treasurer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-12-06 | Exercise or conversion : show line 1 in the form | +7,500 | $3.12 | $23,400 | 124,952 | D |
| 2022-12-06 | Sale : show line 2 in the form | −4,792 | $10.61 | $50,827 | 120,160 | D |
| Open-market sales · 4,792 sh · avg $10.61 · $50,827 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-12-06 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −7,500 | 0 | D |
Loading xslF345X03/doc4.xml…